Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Elexir Pharma AB

Closing information (x1000 DKK)

Closing information 2024/12 2023/12 2022/12
Turnover 87,679 Less Arrow 72,228 Less Arrow 58,190
Financial expenses 0 More Arrow 7 More Arrow 35
Earnings before taxes 10,204 Less Arrow 8,226 Less Arrow 8,015
EBITDA 10,263 Less Arrow 8,315 Less Arrow 8,136
Total assets 39,488 Less Arrow 30,475 Less Arrow 23,379
Current assets 35,986 Less Arrow 28,103 Less Arrow 22,894
Current liabilities 13,714 Less Arrow 8,806 Less Arrow 6,422
Equity capital 24,879 Less Arrow 20,735 Less Arrow 16,279
- share capital 32 More Arrow 34 Less Arrow 33
Employees (average) 19 Less Arrow 15 Less Arrow 10

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 63.0% More Arrow 68.0% More Arrow 69.6%
Turnover per employee 4,615 More Arrow 4,815 More Arrow 5,819
Profit as a percentage of turnover 11.6% Less Arrow 11.4% More Arrow 13.8%
Return on assets (ROA) 25.8% More Arrow 27.0% More Arrow 34.4%
Current ratio 262.4% More Arrow 319.1% More Arrow 356.5%
Return on equity (ROE) 41.0% Less Arrow 39.7% More Arrow 49.2%
Change turnover 17,841 Less Arrow 13,738 Less Arrow 3,959
Change turnover % 26% Less Arrow 23% Less Arrow 7%
Chg. No. of employees 4 More Arrow 5 Less Arrow 0
Chg. No. of employees % 27% More Arrow 50% Less Arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.